It’s so rewarding knowing that with your work, you can make a difference in the lives of people living with a rare disease. With our marketing efforts, we aim to increase awareness of the disease, improve diagnosis, and ensure patients in need have access to this first available treatment in Europe. Because every single life counts. #rewards #marketing #healthcare #rarediseases #diagnosis
Our most recent partnership with Sentynl Therapeutics, Inc. makes Sciensus the exclusive distribution partner in Europe for NULIBRY, a vital treatment for MoCD Type A. This partnership reflects our ongoing mission to ensure access to essential treatments for patients throughout Europe. To read more about our partnership, visit our website https://lnkd.in/edgU9jVB #rarediseases #orphandrugs #biotechs #patientaccess
